AveXis, Inc.

AveXis, Inc.

AveXis, Inc.

Overview
Date Founded

2010

Headquarters

2275 Half Day Road,Suite 200,Bannockburn, IL 60015

Type of Company

Private

Employees (Worldwide)

18

Industries

Biotechnology
Medical Support Services
Hospitals & Patient Services

Company Description

AveXis, Inc. is a clinical-stage gene therapy company that engages in the research and development of novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. Its proprietary gene therapy, Zolgensma, is designed to develop treatment of spinal muscular atrophy. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and is headquartered in Bannockburn, IL.

Contact Data
Trying to get in touch with decision makers at AveXis, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Senior Vice President, General Counsel & Chief Compliance Officer

Chief Scientific Officer & Senior Vice President, Research & Development

Senior Vice President & Chief Human Resources Officer

Senior Vice President, Chief Medical Officer

Chief Business Officer & Senior Vice President

Senior Vice President, Chief Regulatory & Quality Officer

Vice President, Business Operations

President

Senior Director

Senior Director

Paths to AveXis, Inc.
Potential Connections via
Relationship Science
You
AveXis, Inc.
Recent Transactions
Details Hidden

Novartis AG, AveXis, Inc. purchase Astrazeneca Plc /Longmont Manufacturing Operations from AstraZeneca Plc

Details Hidden

Novartis International AG, Novartis AG purchase AveXis, Inc.

Details Hidden

AveXis, Inc. issued USD Common Stock

Transaction Advisors
Investment Advisor

Advised onNovartis International AG, Novartis AG purchase AveXis, Inc.

Escrow Agent

Advised onAveXis, Inc. issued USD Common Stock

Underwriter

Advised onAveXis, Inc. issued USD Common Stock

Legal Advisor

Advised onAveXis, Inc. issued USD Common Stock

Legal Advisor

Advised onAveXis, Inc. issued USD Common Stock

Legal Advisor

Advised onAveXis, Inc. issued USD Common Stock

Advisors & Consultants
Publicist

Associate Director at The W2O Group

Key Stats and Financials As of
Market Capitalization
$7.83B
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
Investors
Details Hidden

Boxer Capital LLC invests in public and private companies located in the US. They target companies operating in the fields of biotech. They provide financing for early stage capital requirements.

Details Hidden

Former Co-Founder & Chief Executive Officer at AveXis, Inc.

Details Hidden

Co-Founder at AveXis, Inc.

Suppliers
REGENXBIO, Inc. Biotechnology | Rockville, MD

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Nationwide Children's Hospital Hospitals & Patient Services | Columbus, OH

Nationwide Children's Hospital engages in the provision of pediatric health care services. It specializes in otolaryngology services; gastroenterology, hepatology and nutrition; hematology, oncology, and blood and marrow transplant; neurology, and sports medicine. The company was founded in 1892 and is headquartered in Columbus, OH.

Asklepios BioPharmaceutical, Inc. Holding Companies | Durham, NC

Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC.

Competitors
Biogen, Inc. Biotechnology - Canyon Country, CA

Biogen has some of the world’s best neurologists and neuroscientists. They engage with physicians and scientific leaders around the world with the aim to further medical research. Their focus on neuroscience, their deep scientific expertise and courage to take risks makes them leaders in the research and development of medicines to transform neuroscience to benefit society. Their technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing their high-quality medicines to market faster. They respect the contributions of health care providers caring for people living with neurological diseases. They honor the important role of caregivers, families and friends who care about them.

Ionis Pharmaceuticals, Inc. Pharmaceuticals - Carlsbad, California

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by AveXis, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of AveXis, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and AveXis, Inc..